Britannia Life Sciences Inc Com C.RLSC

Status Report on 2015 ScoutDS Plans....

[GianniM1]

To recap, these are the 2015 milestones/plans for the Scout that were outlined at the beginning of the year:

January 20, 2015

Miraculins Announces 2015 Plans for Its Scout DS® Non-Invasive Diabetes Screening Technology


_____________________________________________________________________________

To date, based on 2015 NRs, we have the following updates / dispositions on the status of each milestone:

1) Developing Primary Sales & Distribution Channels

a) Retail Pharmacy/Grocery Chain -

STATUS: In Process

January 27, 2015

Miraculins Announces Retail Pharmacy Pilot for Its Scout DS® Non-Invasive Diabetes Screening Technology

March 5, 2015

Miraculins Reports on Positive Results as the First Pharmacy Pilot for the Scout DS® Diabetes Screening Kiosk Nears Completion

b) Workplace Screenings -

STATUS: In Process

July 30, 2015

Miraculins Signs Letter of Intent With New Leaf Health to Distribute the Scout DS® Diabetes Screen in UK Workplace Wellness Market

2) Advancing Chinese SFDA Clearance

STATUS: In Process

May 22, 2015

Miraculins Updates Market on Regulatory Progress in China for its Scout DS® Diabetes Screening Device

3) Establishing Scout DS® Manufacturing

STATUS: Unknown

I contacted AvoPhotonics (Canada) to obtain information on the Scout production. AvoPhotonics could not discuss confidential information.

4) Proceeding on U.S. FDA Clearance Submissions

STATUS: In Process

February 18, 2015

Miraculins Provides Pre-Submission De Novo Documentation to the FDA for Its Scout® Diabetes Technology

April 28, 2015

Miraculins Receives Guidance from U.S. FDA Related to Its Scout® Device as an Aid in the Identification of Pre-Diabetes

August 13, 2015

Miraculins Makes Supplemental Filing With U.S. FDA Related to De Novo Marketing Clearance Pathway of Its Scout® Device

5) Appointment of a Scout DS® Medical Advisory Board

STATUS: Complete

March 10, 2015

Miraculins Appoints Leading Occupational Health Physician to the Scout DS® Medical Advisory Board

6) Other Developments/NR


February 4, 2015

Miraculins Inc. CEO Interviewed by BTV and The Life Sciences Report

June 4, 2015

Promising Results from Miraculins and Amway Scout DS® Study Accepted for the 23rd World Congress of Dermatology

July 6, 2015

Scout® Research Receives Attention at Recent American Diabetes Association Scientific Sessions

(please correct/update if not accurate)